Hot Features
Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. The company's first commercial product, COPIKTRA (duvelisib) is indicated for the treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia/... Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. The company's first commercial product, COPIKTRA (duvelisib) is indicated for the treatment of adult patients with relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma after at least two prior therapies and relapsed or refractory follicular lymphoma after at least two prior systemic therapies. The company's product pipeline candidate, defactinib, is a focal adhesion kinase inhibitor in development for the treatment of cancers where there are limited treatment options, including lung, ovarian, lymphoma, pancreatic, and other advanced cancers. Mehr anzeigen
Completed rolling NDA submission for avutometinib and defactinib combination in recurrent KRAS mutant low-grade serous ovarian cancer in October 2024 Company seeking accelerated approval and...
Recurrent low-grade serous ovarian cancer is a rare cancer with no FDA-approved treatments Company seeking accelerated approval and priority review of its NDA submission in patients with KRAS...
Verastem Oncology (Nasdaq: VSTM), a biopharmaceutical company committed to advancing new medicines for patients with cancer, today announced that its management team will participate in the...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.04 | -0.968523002421 | 4.13 | 4.285 | 3.72 | 740668 | 3.91449629 | CS |
| 4 | 0.79 | 23.9393939394 | 3.3 | 4.8 | 3.17 | 959862 | 3.93981506 | CS |
| 12 | 1.63 | 66.2601626016 | 2.46 | 4.8 | 2.34 | 843293 | 3.32559597 | CS |
| 26 | -7.98 | -66.1143330572 | 12.07 | 12.33 | 2.1 | 934179 | 3.40712862 | CS |
| 52 | -2.38 | -36.7851622875 | 6.47 | 14.22 | 2.1 | 535421 | 4.28275214 | CS |
| 156 | -31.91 | -88.6388888889 | 36 | 36.24 | 2.1 | 1125036 | 12.14123794 | CS |
| 260 | -6.8984 | -62.7789305085 | 10.9884 | 59.22 | 2.1 | 2093687 | 21.84900896 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
